PMC:7594251 / 16621-16768
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T67710 | 40-41 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T126 | 73-75 | Chemical | denotes | 1H | http://purl.obolibrary.org/obo/CHEBI_49637 |
T127 | 141-146 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
174 | 73-75 | Chemical | denotes | 1H | |
175 | 80-83 | Chemical | denotes | 13C | MESH:C000615229 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T117 | 0-147 | Sentence | denotes | The goal of the study was to examine if a metabolomics approach based on 1H and 13C offers significant improvements when comparing potential drugs. |